Clinical Trial Update: Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the mechanism by which fatty acids impair glucose-stimulated insulin secretion, in the context of insulin resistance and pancreat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: University Health Network, Toronto | Conditions: Insulin Resistance Syndrome X, Pancreatic Beta Cell Function | Phase 4 | Status: COMPLETED